Reproducibility of p53 immunohistochemistry in bladder tumors

Lisa M. McShane, Roger Aamodt, Carlos Cordon-Cardo, Richard J Cote, David Faraggi, Yves Fradet, H. Barton Grossman, Amy Peng, Sheila E. Taube, Frederic M. Waldman

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

The National Cancer Institute Bladder Tumor Marker Network conducted a study to evaluate the reproducibility of immunohistochemistry for measuring p53 expression in bladder tumors. Fifty paraffin blocks (10 from each of the five network institutions) were chosen at random from among high-grade invasive primary bladder tumors. Two sections from each block were sent to each laboratory for staining and scoring, and then all sections were randomly redistributed among the laboratories for a second scoring. Intra- and interlaboratory reproducibility was assessed with regard to both staining and scoring. For overall assessments of p53 positivity, the results demonstrated that intralaboratory reproducibility was quite good. Concordance across the five participating laboratories was high for specimens exhibiting no or minimal nuclear immunostaining of tumor cells or high percentages of tumor cells with nuclear immunoreactivities. However, there was a reduced level of concordance on specimens with percentages of stained tumor cells in an intermediate range. The discordancies were due mainly to staining differences in one of the five laboratories and scoring differences in another laboratory. These results indicate that some caution must be used in comparing results across studies from different groups. Standardization of staining protocols and selection of a uniform threshold for binary interpretation of results may improve assay reproducibility between laboratories.

Original languageEnglish
Pages (from-to)1854-1864
Number of pages11
JournalClinical Cancer Research
Volume6
Issue number5
StatePublished - May 1 2000
Externally publishedYes

Fingerprint

Urinary Bladder Neoplasms
Immunohistochemistry
Staining and Labeling
Neoplasms
National Cancer Institute (U.S.)
Tumor Biomarkers
Paraffin

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

McShane, L. M., Aamodt, R., Cordon-Cardo, C., Cote, R. J., Faraggi, D., Fradet, Y., ... Waldman, F. M. (2000). Reproducibility of p53 immunohistochemistry in bladder tumors. Clinical Cancer Research, 6(5), 1854-1864.

Reproducibility of p53 immunohistochemistry in bladder tumors. / McShane, Lisa M.; Aamodt, Roger; Cordon-Cardo, Carlos; Cote, Richard J; Faraggi, David; Fradet, Yves; Barton Grossman, H.; Peng, Amy; Taube, Sheila E.; Waldman, Frederic M.

In: Clinical Cancer Research, Vol. 6, No. 5, 01.05.2000, p. 1854-1864.

Research output: Contribution to journalArticle

McShane, LM, Aamodt, R, Cordon-Cardo, C, Cote, RJ, Faraggi, D, Fradet, Y, Barton Grossman, H, Peng, A, Taube, SE & Waldman, FM 2000, 'Reproducibility of p53 immunohistochemistry in bladder tumors', Clinical Cancer Research, vol. 6, no. 5, pp. 1854-1864.
McShane LM, Aamodt R, Cordon-Cardo C, Cote RJ, Faraggi D, Fradet Y et al. Reproducibility of p53 immunohistochemistry in bladder tumors. Clinical Cancer Research. 2000 May 1;6(5):1854-1864.
McShane, Lisa M. ; Aamodt, Roger ; Cordon-Cardo, Carlos ; Cote, Richard J ; Faraggi, David ; Fradet, Yves ; Barton Grossman, H. ; Peng, Amy ; Taube, Sheila E. ; Waldman, Frederic M. / Reproducibility of p53 immunohistochemistry in bladder tumors. In: Clinical Cancer Research. 2000 ; Vol. 6, No. 5. pp. 1854-1864.
@article{954e708fd1e84225b2a9ae556e5ec972,
title = "Reproducibility of p53 immunohistochemistry in bladder tumors",
abstract = "The National Cancer Institute Bladder Tumor Marker Network conducted a study to evaluate the reproducibility of immunohistochemistry for measuring p53 expression in bladder tumors. Fifty paraffin blocks (10 from each of the five network institutions) were chosen at random from among high-grade invasive primary bladder tumors. Two sections from each block were sent to each laboratory for staining and scoring, and then all sections were randomly redistributed among the laboratories for a second scoring. Intra- and interlaboratory reproducibility was assessed with regard to both staining and scoring. For overall assessments of p53 positivity, the results demonstrated that intralaboratory reproducibility was quite good. Concordance across the five participating laboratories was high for specimens exhibiting no or minimal nuclear immunostaining of tumor cells or high percentages of tumor cells with nuclear immunoreactivities. However, there was a reduced level of concordance on specimens with percentages of stained tumor cells in an intermediate range. The discordancies were due mainly to staining differences in one of the five laboratories and scoring differences in another laboratory. These results indicate that some caution must be used in comparing results across studies from different groups. Standardization of staining protocols and selection of a uniform threshold for binary interpretation of results may improve assay reproducibility between laboratories.",
author = "McShane, {Lisa M.} and Roger Aamodt and Carlos Cordon-Cardo and Cote, {Richard J} and David Faraggi and Yves Fradet and {Barton Grossman}, H. and Amy Peng and Taube, {Sheila E.} and Waldman, {Frederic M.}",
year = "2000",
month = "5",
day = "1",
language = "English",
volume = "6",
pages = "1854--1864",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - Reproducibility of p53 immunohistochemistry in bladder tumors

AU - McShane, Lisa M.

AU - Aamodt, Roger

AU - Cordon-Cardo, Carlos

AU - Cote, Richard J

AU - Faraggi, David

AU - Fradet, Yves

AU - Barton Grossman, H.

AU - Peng, Amy

AU - Taube, Sheila E.

AU - Waldman, Frederic M.

PY - 2000/5/1

Y1 - 2000/5/1

N2 - The National Cancer Institute Bladder Tumor Marker Network conducted a study to evaluate the reproducibility of immunohistochemistry for measuring p53 expression in bladder tumors. Fifty paraffin blocks (10 from each of the five network institutions) were chosen at random from among high-grade invasive primary bladder tumors. Two sections from each block were sent to each laboratory for staining and scoring, and then all sections were randomly redistributed among the laboratories for a second scoring. Intra- and interlaboratory reproducibility was assessed with regard to both staining and scoring. For overall assessments of p53 positivity, the results demonstrated that intralaboratory reproducibility was quite good. Concordance across the five participating laboratories was high for specimens exhibiting no or minimal nuclear immunostaining of tumor cells or high percentages of tumor cells with nuclear immunoreactivities. However, there was a reduced level of concordance on specimens with percentages of stained tumor cells in an intermediate range. The discordancies were due mainly to staining differences in one of the five laboratories and scoring differences in another laboratory. These results indicate that some caution must be used in comparing results across studies from different groups. Standardization of staining protocols and selection of a uniform threshold for binary interpretation of results may improve assay reproducibility between laboratories.

AB - The National Cancer Institute Bladder Tumor Marker Network conducted a study to evaluate the reproducibility of immunohistochemistry for measuring p53 expression in bladder tumors. Fifty paraffin blocks (10 from each of the five network institutions) were chosen at random from among high-grade invasive primary bladder tumors. Two sections from each block were sent to each laboratory for staining and scoring, and then all sections were randomly redistributed among the laboratories for a second scoring. Intra- and interlaboratory reproducibility was assessed with regard to both staining and scoring. For overall assessments of p53 positivity, the results demonstrated that intralaboratory reproducibility was quite good. Concordance across the five participating laboratories was high for specimens exhibiting no or minimal nuclear immunostaining of tumor cells or high percentages of tumor cells with nuclear immunoreactivities. However, there was a reduced level of concordance on specimens with percentages of stained tumor cells in an intermediate range. The discordancies were due mainly to staining differences in one of the five laboratories and scoring differences in another laboratory. These results indicate that some caution must be used in comparing results across studies from different groups. Standardization of staining protocols and selection of a uniform threshold for binary interpretation of results may improve assay reproducibility between laboratories.

UR - http://www.scopus.com/inward/record.url?scp=0034030369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034030369&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 1854

EP - 1864

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 5

ER -